BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 23151877)

  • 1. Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling.
    Franklin JM; Carrasco GA
    Synapse; 2013 Mar; 67(3):145-59. PubMed ID: 23151877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT(2A) and dopamine D₂ receptors in rat prefrontal cortex.
    Franklin JM; Carrasco GA
    J Psychopharmacol; 2012 Oct; 26(10):1333-47. PubMed ID: 22791651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors.
    Franklin JM; Vasiljevik T; Prisinzano TE; Carrasco GA
    Pharmacol Res; 2013 Feb; 68(1):46-58. PubMed ID: 23174265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-protein receptor kinase 5 regulates the cannabinoid receptor 2-induced up-regulation of serotonin 2A receptors.
    Franklin JM; Carrasco GA
    J Biol Chem; 2013 May; 288(22):15712-24. PubMed ID: 23592773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid 2 receptor- and beta Arrestin 2-dependent upregulation of serotonin 2A receptors.
    Franklin JM; Vasiljevik T; Prisinzano TE; Carrasco GA
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):760-7. PubMed ID: 22841827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists.
    Ribeiro R; Wen J; Li S; Zhang Y
    Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():1-14. PubMed ID: 23219970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB
    Olianas MC; Dedoni S; Onali P
    Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats.
    Franklin JM; Mathew M; Carrasco GA
    Neurosci Lett; 2013 Aug; 548():165-9. PubMed ID: 23721787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid 2 receptors regulate dopamine 2 receptor expression by a beta-arrestin 2 and GRK5-dependent mechanism in neuronal cells.
    Franklin JM; Broseguini de Souza RK; Carrasco GA
    Neurosci Lett; 2021 May; 753():135883. PubMed ID: 33838258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors.
    Song S; Kong X; Borlongan C; Sava V; Sanchez-Ramos J
    Cannabis Cannabinoid Res; 2021; 6(1):48-57. PubMed ID: 33614952
    [No Abstract]   [Full Text] [Related]  

  • 11. Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.
    Calik MW; Carley DW
    PLoS One; 2014; 9(10):e111412. PubMed ID: 25350456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of neuronal excitability by serotonin-NMDA interactions in prefrontal cortex.
    Zhong P; Yuen EY; Yan Z
    Mol Cell Neurosci; 2008 Jun; 38(2):290-9. PubMed ID: 18455431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of cannabinoid CB
    Li L; Dong X; Tu C; Li X; Peng Z; Zhou Y; Zhang D; Jiang J; Burke A; Zhao Z; Jin L; Jiang Y
    Br J Pharmacol; 2019 Apr; 176(7):890-905. PubMed ID: 30707759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
    Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
    Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic cannabinoids produce CB₁-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors.
    Seyrek M; Kahraman S; Deveci MS; Yesilyurt O; Dogrul A
    Eur J Pharmacol; 2010 Dec; 649(1-3):183-94. PubMed ID: 20868676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p90 Ribosomal S6 kinase 2, a novel GPCR kinase, is required for growth factor-mediated attenuation of GPCR signaling.
    Strachan RT; Allen JA; Sheffler DJ; Roth BL
    Biochemistry; 2010 Mar; 49(12):2657-71. PubMed ID: 20136148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
    Calik MW; Carley DW
    Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondhand smoke exposure causes bronchial hyperreactivity via transcriptionally upregulated endothelin and 5-hydroxytryptamine 2A receptors.
    Cao L; Zhang Y; Cao YX; Edvinsson L; Xu CB
    PLoS One; 2012; 7(8):e44170. PubMed ID: 22952915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Kokona D; Thermos K
    Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.